CD70 靶向 HIT-CAR-T 细胞对乳腺癌患者来源异种移植瘤的控制
Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.
肿瘤细胞治疗研究
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 1 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov、CDE 与 ChiCTR 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.
MEMBER ACCOUNT
登录成功会直接打开下一页。